Sentences with phrase «make use of a vaccine»

Anytime a veterinarian chooses to make use of a vaccine, Lyme disease...

Not exact matches

Raising organic meat is far more than just making sure animals are free ranging and grass fed, it's equally about producing cattle without synthetic growth hormones, limiting vaccine use, not using routine antibiotics, breeding using natural methods, stress free weaning that allows for the ethological needs of mothers and young, access at all times to unfiltered sunlight and not using electric prodders as a routine management method.
The Vaccine Guide gives parents the information they need in an organized step - by - step format to make decisions about the use of vaccines in their children.
Even where great efforts are made to prevent bacterial infections through animal husbandry techniques, bio-security and use of vaccines, there are occasions when animals will become sick and require treatment with an antibiotic.
And a new analysis of the STEP trial, published last November in Proceedings of the National Academy of Sciences USA, provides a warning that the very vectors (adenoviruses, which are also employed in other vaccine development work) used to distribute the inactive HIV strains can actually make the immune system more vulnerable to infection by recruiting susceptible T cells to mucous membranes, where they are more likely to be infected during sexual activity.
Most of the monkeys used to make early polio vaccine came from India, where none is known to be naturally infected with SIVs.
«Using protein engineering tools, we can look at a million or a billion variants of an antigen and pull out variants that we think would make a better vaccine,» says Ackerman.
«We think we can use our molecular, rational design approaches to make a better flu vaccine for people who really need it,» says study leader Andrew Pekosz, PhD, an associate professor in the Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health.
After several days of incubation the eggs are opened and the virus is removed, purified and used to make the vaccine, as a 2004 Scientific American article points out.
The advantage of Novavax's approach is that a vaccine can be made rapidly and in high volume, compared with the egg - based approach that's used today, says Ted Ross, an associate professor of microbiology and molecular genetics at the University of Pittsburgh's Center for Vaccine Researchvaccine can be made rapidly and in high volume, compared with the egg - based approach that's used today, says Ted Ross, an associate professor of microbiology and molecular genetics at the University of Pittsburgh's Center for Vaccine ResearchVaccine Research (CVR).
Also, to reiterate one of the points made in the article, a vaccination campaign using only a malaria - transmission blocking vaccine (TBV) would indeed confer direct benefit to the immunized individual.
Vaccines block virus entry by making good use of such responses.
Examples include changing policies to encourage older adults to remain part of the workforce for longer (e.g., removing tax disincentives to work past retirement age), emphasising low - cost disease prevention and early detection rather than treatment (eg, reducing salt intake and increasing uptake of vaccines), making better use of technology (eg, mobile clinics for rural populations), and training health - care staff in the management of multiple chronic conditions.
By contrast, the new Zika candidate vaccine uses tiny strands of RNA that hold the genetic codes for making viral proteins.
The Swiss - based pharmaceutical company said that it had made 10 liters of vaccine that it will use in pre-clinical studies and maybe early clinical trials.
While this year's vaccine is a much better match to the circulating seasonal strains of influenza, the shifty nature of the virus and the need to pick the viruses used to make global vaccine stocks well before the onset of the flu season can make vaccine strain selection a shot in the dark.
A vaccine called IPV, made of dead viruses, exists but is too expensive for poor countries, which routinely use tOPV.
For that reason, he adds, «it would be disappointing to me if these kinds of forecasts got used to make critical decisions for vaccine X versus vaccine Y.»
«It is still worthwhile to encourage the immune system to make a greater quantity of antibodies, even if their quality does not rise appreciably, and the value of vaccination may be greater when the flu vaccine strains are not identical to those used in previous seasons» vaccines,» he says.
One of the most contentious and closely scrutinized decisions before the FDA concerns Provenge, a proposed therapeutic vaccine made by Dendreon for use against prostate cancer.
If there's any silver lining in this, we need to make sure that some of the therapeutics and vaccines that have been on an experimental level so far, that we really use this opportunity to make sure we have tools, real - world, available tools for people, hopefully for this outbreak, but if not for this outbreak for the next outbreak, and make sure that we have something of worth that comes out of this.
Pertactin is one of the three proteins, made from purified extracts of Bordetella pertussis bacteria, which are present in the vaccine currently used in Australia.
Asian Flu affected 17 per cent and the most recent pandemic, Hong Kong Flu, made around 8 per cent of the adult population sick, despite the use of vaccines in both cases.
Since T cells can only recognize neoantigens that are «presented» to them by HLA molecules of the immune system, a key step in making the vaccine is using computer algorithms to predict which neoantigen peptides will bind strongly to the HLA molecules for recognition by T cells.
In the face of shortage, or differential access, genetic information could be used to make triage decisions or decide who receives a vaccine or therapy.
«We've known for some time that there is a region of HA, the stem, that does not change and is present on all flu A viruses, and if we can use only that part in the vaccine we could raise immunity to many different viruses at the same time, but it has been technically challenging to make a vaccine that works in that way.
The therapeutic or treatment vaccine Axalimogene Filolisbac, which is given intravenously, makes use of the ability of the Listeria bacteria to infect cells.
Here we report the use of a liposomal vaccine for the generation of a monoclonal antibody with particular characteristics that makes it a valuable tool for fundamental studies as well as a candidate antibody for diagnostic and therapeutic applications.
The alternative low - risk strategy is to use a vaccine made up of dead protein.
Sept. 12, 2017 - A multidisciplinary scientific team at Lawrence Livermore National Laboratory (LLNL) has made significant advances in developing a vaccine for chlamydia using synthetic biology, sponsored by a two - year National Institutes of Health (NIH) grant.
The Delta VP30 technology has been approved by the National Institutes of Health for use under Biosafety Level 2 conditions and has been utilized safely for a decade to study the basic biology of the virus, identify potential antiviral compound candidates, and make the whole - virus vaccine.
VXGN has other potentially valuable assets, including a «a state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.
VXGN has other potentially valuable assets, including a «state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.
To help ensure proper use of reproductive vaccines, it is a shared responsibility among veterinarians, producers and the Technical Services team from Zoetis to make sure everyone involved understands labels and administers products correctly.
So with the unregulated and unpoliced use of genetic engineering, the making of a bird flu vaccine in Mexico hooking up a H5N1 influenza with the rabies virus, this chimera is now at large.
Given the serious unintended effects that can manifest themselves after a vaccine has been given, individuals want to begin making use of more critical thought when making selections about vaccination protocols.
I have no commercial interest in any of these companies nor any experience purchasing anything from them or using their products; they are simply resources for single - antigen vaccines of which I've been made aware.
As if decisions to use vaccines were always made be infallible people of infinite wisdom.
Companies making climate friendly refrigerators and freezers for biomedical applications include Mayekawa, which uses air as a refrigerant, and Vestfrost's «Green Line» biomedical freezers and refrigerators and Sure Chill vaccine refrigerators, both of which use propane, a climate friendly refrigerant.
a b c d e f g h i j k l m n o p q r s t u v w x y z